Bupa today announces the appointments of Philip Broadley as a Non-Executive Director with effect from 1 April 2026 and Professor Bruno Holthof and Gill Whitehead, OBE as Non-Executive Directors from 10 April 2026.
Philip will join the Audit, Risk and Remuneration Committees, Bruno will join the Remuneration Committee and Gill will join the Risk Committee. All three will also join the Nomination & Governance Committee.
Philip brings extensive international life sciences and financial services experience having worked in both senior executive and non-executive board roles in four FTSE100 listed companies. Previously he was Group Finance Director of Prudential plc from 2000 until 2008 and subsequently held the same position at Old Mutual plc from 2008 until 2014. He has served as Chairman of 100 Group of Finance Directors and as a member of the Code Committee of The Takeover Panel. He was a director of Legal & General Group plc from 2016 until 2025, chairing the audit committee for six years and serving for a time as Senior Independent Director. Prior to his board roles, Mr. Broadley began his career at Arthur Andersen in 1983, becoming a partner in 1993, where he specialised in auditing banks and insurance companies. Mr. Broadley is a Fellow of the Institute of Chartered Accountants in England and Wales. Mr. Broadley graduated in Philosophy, Politics and Economics from St. Edmund Hall, Oxford, where he is now a St. Edmund Fellow. He holds an MSc in Behavioural Science from the London School of Economics. Philip is Chair of Lancashire Holdings Limited and Senior Independent Director and Audit Committee Chair at AstraZeneca PLC.
Bruno brings in-depth knowledge of healthcare systems in different markets, with an operational understanding of healthcare services and more than 10 years’ experience on the boards of public listed companies. He has previously served as CEO of Oxford University Hospitals NHS Foundation Trust (2015-2022) and CEO of the Antwerp Hospital Network (2004-2015). Prior to that he was a partner at McKinsey & Company, serving a wide range of healthcare clients in Europe and the United States and gained significant expertise in the areas of strategy, organisation and operations. He holds an MBA from the Harvard Business School and an MD/PhD from the University of Leuven. He is Investment Partner of the EQT Life Sciences Health Economics Funds and Visiting Professor of Health Innovation at the University of Oxford. Non-Executive Chair of Financière de Tubize, reference shareholder of UCB, a global biopharma company and Non-Executive Chair of Tristel plc, an AIM listed company providing innovative disinfection solutions to hospitals worldwide.
Gill brings significant executive and regulatory experience in the technology and media sectors having worked at Ofcom, Google, Channel 4 and the BBC. She is a Visiting Policy Fellow at the University of Oxford’s Internet Institute focusing on global developments in AI safety, and is a Responsible AI advisory panel member to UK Government Digital Services. Gill was Group Director, Online Safety at Ofcom until late 2024 and Chair of the Global Online Safety Regulator Network for 2024. Before that, from 2021 to early 2023, she was Chief Executive of the Digital Regulators Forum, a collaboration between the UK’s largest regulators. Gill spent four years as a Senior Director at Google, leading Market Insights and Client Solutions & Analytics teams, after holding several digital strategy and data leadership roles at Channel 4 and the BBC. She began her career at Deloitte Consulting. Gill's Board experience spans FTSE 50 companies, public bodies and sport. She has previously served as a Non-Executive Director of the Financial Ombudsman Service and Camelot (operator of the UK National Lottery). She is currently a Non-Executive Director at NatWest Group plc, Informa plc, the British Olympic Association, and was Chair of the Women’s Rugby World Cup (England) 2025. She received an OBE in the 2026 King's New Year Honours for services to women’s rugby.
Don Robert, CBE, Bupa Board Chair, said: “We are delighted to welcome Philip, Bruno and Gill to the Bupa Board. Their appointments will strengthen the financial services, clinical and digital experience on the Board at an important time in Bupa’s strategic development, and I look forward to working with them all.”
The British United Provident Association Limited (BUPA 1025Z LN)
[ENDS]
About Bupa
Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving 68 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in Australia, the UK, Spain, Poland, Chile, Hong Kong SAR, India, Türkiye, Brazil, Mexico and New Zealand. We also have associate businesses in Saudi Arabia.
For more information, visit bupa.com
Media contacts [email protected]
